SpectraScience Engages European Contract Research Organization to Manage Clini...(n and cervix respectively. As noted abo...)

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically illuminate tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company's LUMA imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

    Contact:
    SpectraScien
'/>"/>
SOURCE  SpectraScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 
Related biology technology :

1. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
2. SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript
3. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
4. SpectraScience Strengthens Leadership Team With Four Key Hires
5. Jim Dorst Joins SpectraScience as CFO
6. SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
7. CardioGenics Holdings Inc. Engages Gilford Securities As Investment Banker
8. Merck Engages PharmaVentures to Assist in the Divestment of its Italian Research Centre IRBM
9. Healthplace America Engages Robert A. Yungk to Provide Services as Chief Strategy Officer
10. Gentag, Inc. Engages US and UK Firms to Explore Strategic Options
11. MMR Information Systems, Inc. Engages Houlihan Smith